MedPath

Piloting a Healthy Aging Cohort in Manitoba

Active, not recruiting
Conditions
Healthy Aging
Registration Number
NCT06100224
Lead Sponsor
University of Manitoba
Brief Summary

The purpose of this study is to set up and pilot baseline data collection for a prospective cohort designed to explore the relationships between medical fitness facility usage, lifestyle behaviours and health outcomes as individuals age. Additionally, this pilot study will set up the overall objectives for the larger, prospective cohort study using a public engagement participatory approach with public/patient partners involved in determining which healthy aging outcomes to include.

Detailed Description

This project will cover the set-up, development, and user-testing of the baseline visit data collection in the first 20 participants. Data will be collected on physical activity, diet, sleep, stress, cognition, frailty, health history (including diabetes, alcohol and smoking), facility and program usage at the Wellness Institute (WI), height, weight, volitional oxygen intake (VO2 max), blood pressure, heart rate, clinical chemistry, urinalysis, body composition, social determinants of health, and wellbeing.

Additionally, a public engagement participatory approach will be used to determine which healthy aging outcomes are important to study, including discussion on research priorities, research question, research design, data collection approaches, outcome measures, analysis of results, relevance of findings, and dissemination of findings. Therefore, this pilot project will include the formation of a project advisory group that will include public/patient partners. The advisory group members will discuss ideas around healthy aging and lifestyle and what outcomes are most important to them; and will provide information on the reasons for joining as well as the use of the medical fitness facility, any barriers they face and program needs. The project advisory group will be an integral part of this pilot project. The information obtained from the advisory group meetings and the pilot project will be used to develop the outcomes for the larger cohort study.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Male or female, aged 30 years or above.
  • Able to communicate in English and provide written informed consent
  • Current member of the Wellness Institute
  • Access to a device such as an android or iOS smartphone or tablet for use with the dietary tracking application.
Exclusion Criteria

• Female participant who is pregnant or lactating

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Body Mass Index (BMI)At baseline

Body Mass Index will be measured

Sleep Quality AssessmentAt baseline

Measured using the Pittsburgh Sleep Quality Index Questionnaire (PSQI), an effective instrument used to measure the quality and patterns of sleep in adults. It differentiates "poor" from "good" sleep quality by measuring seven areas (components): subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medications, and daytime dysfunction.

Physical ActivityAt Baseline

Measured using the International Physical Activity Questionnaire - Long form (IPAQ-L)

Sleep AssessmentAt baseline

An ActiGraph activity monitor will be used to measure sleep quality patterns for 7 days, wtih participants asked to wear the monitor at all times, including when they sleep.

StressAt baseline

The Perceived Stress Questionnaire (PSQ) will be completed to assess stressful life events and circumstances that tend to trigger or exacerbate disease symptoms.

FrailtyAt baseline

The Short Physical Performance Battery (balance test, gait speed, and chair stand) and handgrip strength with be collected to measure frailty.

Blood PressureAt baseline

Blood pressure while awake, while asleep, and total will be measured using an ambulatory blood pressure monitor, worn for 3 consecutive days.

uACRAt baseline

Urine albumin to creatinine ratio

UrinalysisAt baseline

Dipstick urinalysis will be measured

Wellbeing - Self-efficacyAt baseline

The Multidimensional Health Locus of Control (MHLC) Scale Form A will be used to measure self-efficacy

Wellbeing - LonelinessAt baseline

The UCLA Loneliness Scale will be sued to measure loneliness.

Dietary IntakeAt baseline

The RxFood App will be used to measure dietary intake over 3 full days.

Physical Activity AssessmentAt baseline

An Actigraph activity monitor will be used to measure physical activity for 7 days, wtih participants asked to wear the monitor at all times.

Cognition AssessmentAt baseline

The Montreal Cognitive Assessment Score (MoCA) will be used to give insight into how participants mentally process information.

Body WeightAt baseline

Body weight will be measured.

CholesterolAt baseline

Total cholesterol, HDL-C, LDL-C, triglycerides, total cholesterol/HDL ratio

Health HistoryAt baseline

Collected using the PACMan Health History and Facility Usage Questionnaire

Fitness LevelAt baseline

Measured by volitional oxygen intake, otherwise known as VO2 max, using the Ebbeling Treadmill Test (a submaximal walking test)

DietAt baseline

Measured using the Mindful Eating Questionnaire and the 3 Factor Eating Questionnaire

Waist circumferenceAt baseline

Waist circumference will be measured

Facility UsageAt baseline

Participants will complete a questionnaire on attendance in hours per week, and # of times per week, and specific program/facility usage at the Wellness Institute. The Wellness Institute swipe data will be used to record the number of times swiped per week and per month since joining.

HbA1cAt baseline

Hemoglobin A1C

eGFRAt baseline

Estimated glomerular filtration rate.

10-Year Risk of Cardiovascular DiseaseAt baseline

Measured using the Framingham Risk Score

Cardiovascular AssessmentAt baseline

Identification of Metabolic Syndrome and the Framingham Risk Score will be measured.

Body CompositionAt baseline

DEXA scan measurements including total mass, fat mass, lean mass, % fat, visceral adipose tissue, total body bone mineral density), and relative skeletal muscle index (RSMI) will be collected.

Wellbeing - Life SatisfactionAt baseline

The Satisfaction With Life Scale will be used to measure life satisfaction

Wellbeing - DepressionAt baseline

The Center for Epidemiologic Studies Short Depression Scale (CES-D-10) will be used to measure depression

Social Determinants of HealthAt baseline

Access to general medical and dental care, postal code, household income, education level and marital status will be collected.

Wellbeing - Quality of LifeAt baseline

the EQ-5D-5L will be collected to measure quality of life.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Seven Oaks Hospital Chronic Disease Innovation Centre

🇨🇦

Winnipeg, Manitoba, Canada

© Copyright 2025. All Rights Reserved by MedPath